老年急性冠脉综合征合并心源性休克的治疗  

Treatment of Acute Coronary Syndrome with Cardiogenic Shock in Elderly Patients

作　　者：杜梦阳[1] 袁晋青[1] 

机构地区：[1]北京协和医学院中国医学科学院国家心血管病中心阜外医院心血管内科,北京市100037

出　　处：《中国分子心脏病学杂志》2017年第2期2064-2067,共4页Molecular Cardiology of China

基　　金：国家自然科学基金(81470486);十三五国家重点研发计划项目(2016YFC1301301)

摘　　要：老年人急性冠脉综合征合并心源性休克的治疗是临床十分棘手的问题,药物治疗方面的临床研究极为有限。再灌注治疗方面,经过筛选的老年人早期进行血运重建对于预后有着积极的意义,即使不适宜介入治疗的患者接受适当的溶栓治疗方案总体结局也要优于药物保守治疗。主动脉内球囊反搏术在急性冠脉综合征合并心源性休克老年患者中的应用尚需谨慎。尽管新型循环辅助装置尽管显示了良好的前景,但在老年人中的应用还有待进一步研究和完善。The treatment of acute coronary syndrome with cardiogenic shock in the elderly has become a very difficult clinical problem. Clinical research on drug treatment is extremely limited. Reperfusion therapy. Early screening of elderly blood revascularization has a positive significance for the prognosis, even if not suitable for interventional therapy in patients receiving appropriate thrombolytic therapy is superior to drug conservative treatment. Intra-aortic balloon pump in patients with cardiogenic shock in the old patients need to be cautious. Although the new circulating assistive device shows good prospects, the application in the elderly remains to be further studied and improved.

关 键 词：急性冠脉综合征 老年人 心源性休克 

分 类 号：R541.4[医药卫生—心血管疾病]